Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details) - Schedule of net proceeds of the public offering

v3.21.2
Stockholders' Equity (Details) - Schedule of net proceeds of the public offering - USD ($)
6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Gross Proceeds:    
Firm shares and exercise of over-allotment option closing $ 51,520,000  
Offering Costs:    
Underwriting discounts and commissions (3,806,400)  
Other offering costs (190,017)  
Net Proceeds $ 47,523,583